THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 418,629 Value ($000) $7,833 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 357,651 Value ($000) $5,222 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 100,778 Value ($000) $1,112 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 14,911 Value ($000) $133 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 66,067 Value ($000) $622 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 150,060 Value ($000) $1,209 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 297,499 Value ($000) $2,523 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 162,073 Value ($000) $1,454 Avg Close $9.27 Range $8.21 - $11.71
Q3 2023
Shares 20,400 Value ($000) $176 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 59,812 Value ($000) $619 Avg Close $11.04 Range $9.98 - $12.03
Q2 2020
Shares 14,990 Value ($000) $315 Avg Close $25.69 Range $20.17 - $31.35
Q1 2019
Shares 4,080 Value ($000) $92 Avg Close $25.36 Range $21.04 - $28.63
Q4 2018
Shares 4,080 Value ($000) $104 Avg Close $27.00 Range $21.70 - $35.48
Q4 2016
Shares 408,880 Value ($000) $13,035 Avg Close $31.02 Range $24.54 - $38.92
Q3 2016
Shares 79,068 Value ($000) $2,865 Avg Close $27.84 Range $21.97 - $37.14
Q2 2016
Shares 23,706 Value ($000) $538 Avg Close $21.59 Range $15.00 - $24.76